Retinal tear: an unusual complication of ocular toxoplasmosis

Ali Riza Cenk Celebi 1 , Ayse Ebru Kilavuzoglu 1 , Ugur Emrah Altiparmak 1 , Cemile Banu Cosar 1 , and Abdullah Ozkiris 1
  • 1 Acibadem University School of Medicine Department of Ophthalmology Istanbul/Turkey

Abstract

Purpose: It is aimed to report on a 16-year-old patient with acquired ocular toxoplasmosis complicated by a retinal tear. Methods: Retrospective medical chart review Results: A 16-year-old Caucasian female presented with vision loss in her right eye. In addition to a white active lesion between the fovea and the optic nerve head, marked vitreous opacification was noted. She was diagnosed with ocular toxoplasmosis. The patient was treated with oral azithromycin, clindamycin, and trimethoprimsulfamethoxazole. One month later, retinochoroiditis resolved and vitreous cleared. Three months after onset, patient presented with floaters in the right eye and a retinal tear was located at the temporal region of the retina. Prophylactic argon laser treatment that encircled the retinal tear was performed. No other abnormalities were noted during 6 months of follow-up. Conclusions: Retinal tear associated with ocular toxoplasmosis is rare; however, a retinal tear can occur due to vitreoretinal traction following post-inflammatory structural alteration of the vitreous. Retinal tears may be seen during the healing phase, when the inflammation turns into tightening of vitreous substance. Careful retinal examination in cases of ocular toxoplasmosis is warranted, especially in patients with severe vitreous inflammation.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] McCannel C.A., Holland G.N., Helm C.J., Cornell P.J., Winston J.V., Rimmer T.G., Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group, Am. J. Ophthalmol., 1996, 121, 35-46

  • [2] Sengun A., Karadağ R., Karakurt A., Saricaoğlu M.S., Abdik O., Hasiripi H., Causes of uveitis in a referral hospital in Ankara, Turkey, Ocul. Immunol. Inflamm., 2005, 13, 45-50

  • [3] Holland G.N., O`Connor G.R., Belfort R. Jr., Remington J.S., Toxoplasmosis. In: Pepose J.S., Holland G.N., Wilhelmus K.R. eds., Ocular Infection & immunity., 1st edn., Mosby, St Louis, MO, pp 1183-1223

  • [4] Klaren V., Kijlstra A., Toxoplasmosis, an overview with emphasis on ocular involvement., Ocul. Immmunol. Inflamm., 2002, 10, 1-26

  • [5] Adan A., Giralt J., Alvarez G., Alforja S., Burés-Jesltrup A., Casaroli-Marano R.P., Corcostegui B., Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis, Eur. J. Ophhalmol., 2009, 19, 1039-1043

  • [6] Perrotta S., Nobili B., Grassia C., Sebastiani A., Parmeggiani F., Costagliola C., Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis, Arch. Ophthalmol., 2003, 121, 1493-1496

  • [7] Bosch-Driessen L.H., Karimi S., Stilma J.S., Rothova A., Retinal detachment in ocular toxoplasmosis, Ophthalmology, 2000, 107, 36-40

  • [8] Lucena Dda R., Ribeiro J.A., Lucena Dda R., de Lucena A.L., Jorge R. [Retinal tears in toxoplasmic retinochoroiditis: case series], Arq. Bras. Oftalmol. 2009, 72, 829-831

  • [9] Bodanowitz S., Hesse L., Schroeder B. [Retinal tear in retinochoroiditis toxoplasmotica], Klin. Monbl. Augenheilkd. 1996, 208, 130-131

  • [10] Dodds E.M., Holland G.N., Stanford M.R., Yu F., Siu W.O., Shah K.H., Ten Dam-van Loon N., Muccioli C., Hovakimyan A., Barisani-Asenbauer T.; International Ocular Toxoplasmosis Research Group, Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am. J. Ophthamol. 2008, 146, 856-865

  • [11] Lafaut B.A., Meire F.M., Leys A.M., Dralands G., De Laey J.J., Vasoproliferative retinal tumors associated with peripheral chorioretinal scars in presumed congenital toxoplasmosis, Graefes. Arch. Clin. Exp. Ophthalmol. 1999, 237,1033-1038

  • [12] Kianersi F., Naderi Beni A., Ghanbari H., Fazel F., Ocular toxoplasmosis and retinal detachment: five case reports. Eur. Rev. Med. Pharmacol. Sci. 2012, 16, 84-89

  • [13] Bosch-Driessen E.H., Rothova A., Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis, Br. J. Ophthalmol. 1998, 82, 858-860

  • [14] Bosch-Driessen L.E., Berendschot T.T., Ongkosuwito J.V., Rothova A., Ocular toxoplasmosis: cinical features and prognosis of 154 patients, Ophthalmology 2002, 109, 869-878

  • [15] Desmettre T., Labalette P., Fortier B., Mordon S., Constantinides G., Laser photocoagulation around the foci of toxoplasmic retinochoroiditis: a descriptive statistical analysis of 35 patients with long-term follow-up, Ophthalmologica 1996, 210, 90-94

  • [16] Tugal-Tutkun I., Corum I., Otük B., Urgancioglu M., Active ocular toxoplasmosis in Turkish patients: a report on 109 cases, Int. Ophthalmol. 2005, 26, 221-228

  • [17] Fardeau C., Romand S., Rao N.A., Cassoux N., Bettembourg O., Thulliez P., Lehoang P., Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am. J. Ophthalmol. 2002, 134, 196-203

  • [18] Johnson M.W., Greven G.M., Jaffe G.J., Sudhalkar H., Vine A.K., Atypical, severe toxoplasmic retinochoroiditis in elderly patients, Ophthalmology 1997, 104, 48-57

OPEN ACCESS

Journal + Issues

Search